SuperSeed Capital Limited Issue of Convertible Loan Notes

RNS Number : 7567I

SuperSeed Capital Limited

28 March 2024

 

SUPERSEED CAPITAL LIMITED

(the "Company")

Related party transaction

Issue of convertible loan notes

 

 

Further to the announcement made on 16 September 2022 in respect of the establishment of a £1,000,000 loan facility through the issue of convertible loan notes (the "Convertible Loan Notes") to the SuperSeed Ventures LLP ("SuperSeed Ventures"), on 3 April 2024 the Company will issue 150,000 Convertible Loan Notes to SuperSeed Ventures for a subscription price of £150,000 (the "Issue").

 

SuperSeed Ventures is a related party of the Company pursuant to the rules of the Aquis Stock Exchange. The independent directors of the Company, having exercised reasonable care, skill and diligence believe that the Issue is fair and reasonable as far as the shareholders of the Company is concerned.

 

SuperSeed Capital Limited (AQSE:WWW) is a company established as a venture capital fund of funds for early-stage AI/SaaS companies. The Company invests in technology-led innovation, primarily through funds managed by SuperSeed Ventures. The Company's principal investment to date is in SuperSeed II LP.

 

 

For more information, please contact:

 

SuperSeed Capital Limited	[phone]
Mads Jensen, Investment Manager
VSA Capital - AQSE Corporate Adviser and Broker	[phone]
Corporate Finance: Simon Barton / Alex Cabral

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NEXUWSURSKUOUAR